2 completed, 1 active not recruiting, 1 recruiting, 1 terminated. 2 Phase 1, 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Active not recruiting 1, Terminated 1 |
| Phase 2 | 2 | Active not recruiting 1, Terminated 1 |
| Phase 3 | 1 | Completed 1 |
Follow Nephroma, Mesoblastic: new trials by email Literature Review of Nephroma, Mesoblastic trials Research Report on Nephroma, Mesoblastic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options Entrectinib - Solid Tumors, CNS Tumors | Phase 1 / Phase 2 | Active not recruiting | Hoffmann-La Roche | 69 | 2016-05-03 | 2026-09-23 |
| Project: Every Child for Younger Patients With Cancer Cytology Specimen Collection Procedure, Medical Chart Review - Adrenal Gland Pheochromocytoma, Carcinoma In Situ | Recruiting | Children's Oncology Group | 75000 | 2015-11-03 | 2026-08-25 | |
| Studying Biomarkers in Samples From Younger Patients With Kidney Cancer Laboratory Biomarker Analysis - Childhood Kidney Neoplasm, Clear Cell Renal Cell Carcinoma | Withdrawn | Children's Oncology Group | 2012-08-22 | 2018-08-07 | ||
| Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors carboplatin, dasatinib, etoposide phosphate - Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor | Phase 1 / Phase 2 | Terminated | City of Hope Medical Center | 7 | 2008-09-03 | 2023-07-14 |
| Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom DNA analysis, polymorphism analysis, laboratory biomarker analysis - Bladder Cancer, Brain and Central Nervous System Tumors | Unknown | Cancer Research UK | 14000 | 2008-02-01 | 2013-08-26 | |
| Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Fentanyl sublingual spray, Placebo - Cancer | Phase 3 | Completed | INSYS Therapeutics Inc | 130 | 2007-10-01 | 2014-03-05 |
| Study of Kidney Tumors in Younger Patients Cytology Specimen Collection Procedure, Laboratory Biomarker Analysis - Adult Cystic Nephroma, Anaplastic Kidney Wilms Tumor | Completed | Children's Oncology Group | 8000 | 2006-02-27 | 2026-05-18 |
Carcinoma, Renal Cell (5) · Central Nervous System Neoplasms (4) · Astrocytoma (3) · Brain Neoplasms (3) · Choroid Plexus Neoplasms (3) · Kidney Neoplasms (3) · Medulloblastoma (3) · Melanoma (3) · Sarcoma (3) · Wilms Tumor (3) · Burkitt Lymphoma (2) · Craniopharyngioma (2) · Desmoid Tumors (2) · Esophageal Neoplasms (2)
Carcinoma (7) · Female Urogenital Diseases (7) · Female Urogenital Diseases and Pregnancy Complications (7) · Kidney Diseases (7) · Male Urogenital Diseases (7) · Neoplasms by Histologic Type (7) · Neoplasms by Site (7) · Neoplasms, Complex and Mixed (7) · Neoplasms, Glandular and Epithelial (7) · Urogenital Diseases (7) · Urogenital Neoplasms (7) · Urologic Diseases (7) · Urologic Neoplasms (7) · Adenocarcinoma (6) · Neoplasms (5)
Amplified Fragment Length Polymorphism Analysis (1) · Blotting, Western (1) · Carboplatin (1) · Dasatinib (1) · Fentanyl (1) · Ifosfamide (1) · Immunohistochemistry (1) · Microarray Analysis (1) · Radiotherapy (1) · entrectinib (1) · etoposide phosphate (1)
Children's Oncology Group (3) · Cancer Research UK (1) · City of Hope Medical Center (1) · Hoffmann-La Roche (1) · INSYS Therapeutics Inc (1)
United States (6) · Canada (3) · Australia (2) · New Zealand (2) · Puerto Rico (2) · United Kingdom (2) · China (1) · France (1) · Germany (1) · Hong Kong (1) · Israel (1) · Italy (1) · Saudi Arabia (1) · Spain (1) · Switzerland (1)
Douglas S Hawkins (1) · Elizabeth A Mullen (1) · Elizabeth Beierle (1) · Judith K. Sato, MD (1) · Larry Dillaha, MD (1) · Paul Pharoah, MD (1)
PMID 22480131, PMID 27020837, PMID 31838007, PMID 32267967, PMID 35395680, PMID 37933882, PMID 38396300, PMID 40086048, PMID 42657661
U10CA098543 (2), 2023 (1), P30CA033572 (1), U10CA180886 (1), UG1CA189958 (1)